Infinity Pharmaceuticals

$1.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-9.50%) Today
-$0.02 (-1.10%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell INFI and other stocks, options, and ETFs commission-free!

About INFI

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA. The listed name for INFI is Infinity Pharmaceuticals, Inc. Common Stock.

CEO
Adelene Q. Perkins
Employees
25
Headquarters
Cambridge, Massachusetts
Founded
1995
Market Cap
116.21M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.02M
High Today
$2.04
Low Today
$1.80
Open Price
$2.04
Volume
1.08M
52 Week High
$2.17
52 Week Low
$0.60

Collections

INFI Earnings

-$0.24
-$0.13
-$0.03
$0.08
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 3

You May Also Like